This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Virtual ClinicalTrials transcend geographic, mobility and economic barriers. Clinicaltrials are medical research projects involving human participants. However, the costs of conducting a full-scale clinicaltrial can be prohibitive, posing barriers to research for cannabis companies.
A first-of-its-kind Phase 3 clinicaltrial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. MAPS is now enrolling participants for a further Phase 3 study that will allow another 50 subjects to access this promising new therapy. View original article.
As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.
9 In a February 2021 article in Nutritional Outlook , Jesse Karagianes, vice president of sales of the CBD natural products company CV Sciences (San Diego, California), was quoted as saying: “[T]he single largest factor which contributed to slow category sales was the deluge of inferior products hitting the market. Accessed July 25, 2021.
In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients. More rigorous clinicaltrials are needed to establish clear guidelines for its use in MS management.
a necessary question to address as medical marijuana becomes more accessible. ClinicalTrial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population.
This article was originally published on Analytical Cannabis and appears here with permission. . Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies. Still, research is ongoing.
However, our drug laws impede research and deny patients access to these highly effective medicines. Firstly, psychedelics are administered infrequently in controlled settings with up to only three treatments shown to produce long lasting benefits in clinicaltrials so far. Secondly, people report being healed.
In recent years, as more clinicaltrial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.
This is despite a limited number of high-quality clinicaltrials investigating the drug’s efficacy for this condition. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders.
Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government. This is at least due to the difficulty and cost involved in accessing a legal prescription. Patient access pathways.
We rate levels of evidence, and a high level may be a controlled randomized clinicaltrial (RCT), but there are also observational studies. states there are dispensaries where most people have access to cannabis drugs. But they’re there and people can have access to them. Dr. Weil: In most U.S.
Strains mentioned in this article include: ACDC Cannatonic G-13 Cinderella 99. 15 Multiple clinicaltrials have shown that linalool in ylang ylang oil and lavender oil “significantly increased calmness.” Of course, accessing the terpene profile of your weed can be as big of a challenge as finding Type II cannabis.
Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. A recently published review article assessing the current state of research noted there were numerous studies supporting significant pain-managing effects. [3] Accessed December 5 2018.
In a previous article, we explored one potential current opportunity for entrepreneurs interested in psychedelics and mycelium— producing non-psychoactive mushroom supplements. 2022 Active FDA ClinicalTrials and State-Regulated Systems. Active FDA Regulated ClinicalTrials*. WRITTEN BY: Vicente Sederberg LLP.
Data collected from MAPS-sponsored Phase 3 clinicaltrials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”.
Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Accelerated timelines to clinicaltrials and expansion of drug development pipeline. Phase 1 clinicaltrials are scheduled for Q3 2022 with Phase 2 trials expected in Q2 2023.
In this article, you’ll learn why and how medical marijuana is effective for treating OCD. Until we have more complete clinicaltrials about the benefits of cannabis for OCD, we can only look to the anecdotal experiences of many people who have used medical marijuana conditions. . What Exactly Does OCD Mean?
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.
The US Food and Drug Administration (FDA) has just approved a new clinicaltrial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. . View original article.
For more background on Radicle ACES methodology and additional insights from collaborators and experts involved in the study, see these Radicle Resources articles. Follow Radicle Science on LinkedIn to stay updated on Radicle ACES and other news. Eric Schudiske, eric@s2spr.com.
Some of this information has since been made publicly available on the TGA’s Medicinal Cannabis Access Data Dashboard – revealing approved medicinal cannabis prescriptions have now reached more than 247,000 – though the data published is not as detailed as that obtained by the researchers. Read their full article at.
Stewart said that he gained access to medical cannabis while living in California and that it’s “perverse” that opioid prescriptions are given out so much more readily than cannabis. In 2019, Newton John detailed her use of cannabis to cope with the symptoms of cancer and stated that everyone should have access to medical marijuana.
This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , ClinicalTrial ID NCT03866174, available at [link].
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Le-Short C.,
Strain names are an unreliable method of finding cannabis that works for you, but for simplicity’s sake, these are the strains mentioned in the article: Harlequin ACDC Cannatonic. If you don’t have access to lab reports, smell the weed before you buy it. Focus vs. flow state. Being able to focus well is essential for any adult.
Dr. Bankole Johnson was featured in a March 5 th 2021 Forbes article, “Dr. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinicaltrials.” A replay of the interview is available on the media section of the Company’s website at: [link]. Ehave, Inc.
By analyzing social, legal, and political barriers to access in this context, we hope to advance the understanding of their potential impact as therapeutics.”. The project also intends to advance research into how psychedelics can heal trauma and how to ensure equitable access to these therapies. View original article.
As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.
This year, we are completing the second Phase 3 clinicaltrial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies.
Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinicaltrials and research using a pharmaceutical formulation of ??5-MeO-DMT We deeply appreciate our value alignment with this team and eagerly anticipate their progress in improving access to these medicines.”.
In this article, we explore the effectiveness of medical marijuana in easing chemotherapy side effects, offering insights into its benefits, challenges, and prospects. Clinicaltrials have highlighted the efficacy of medical marijuana in managing pain, suggesting it as a potential alternative or adjunct to traditional pain medications.
It is hoped that, as a result of these changes, medicinal cannabis products will be more readily and easily accessible to patients through legal channels. We provide an overview of the key findings and recommendations of the Final Report below. Key findings.
This article was originally published on Psychedelic Spotlight . Clinicaltrials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies.
In this article, we explore the role of medical marijuana in addressing insomnia, examining its effectiveness, safety considerations, legal aspects, and practical considerations for patients and healthcare providers. Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals.
Joël Brierre, founder and CEO of the company, said that “everyone on the planet should have access to the life-changing properties of psychedelics.”. View original article. When used properly, 5-MeO-DMT can be one of the most powerful tools known to man, allowing participants a brief yet intense mystical experience,” said Brierre.
In this article, we explore the scientific understanding of THC, exploring its chemical structure, mechanisms of action within the human body, potential health benefits, associated risks, and legal implications. These trials aim to provide more conclusive evidence for its use in mainstream medicine.
Article by Jorge P. This article will examine how courts have responded to claims for cannabis, as an element of future care costs, in personal injury cases. While there is anecdotal evidence that CBD does have beneficial properties, I heard no evidence that that claim has been established through recognized clinicaltrials.
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. A total of 117 articles were retrieved for analysis, the majority of which were news stories for a physician audience.
Our audacious mission is to create the new standard of trust and transparency consumers deserve and healthcare providers demand on these widely accessible potential therapies. For more information on the Radicle ACES study, initial results, and methodology, see this Radicle Resources article.
I want to be a part of the change that sees patients become able to access quality cannabis medicines and to change lives. We will be investing heavily in research and development and clinicaltrials to develop a full range of medicines, ready for registration and marketing authorization in Australia and Europe. .
The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 4) Article 11 shall be worded as follows: ” Article 11. .”;
Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinicaltrials. The Article. Acting on a broad range of cases, all with a medical or injury element, usually on the instructions of insurers.
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. CBD’s anti-seizure properties, demonstrated through clinicaltrials, have made it a game-changer in the epilepsy field.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content